Accelerate Diagnostics, Inc. (AXDX)
AXDX moved a median of -0.12% 30 minutes after news, and -1.76% by the close. How AXDX actually reacts to news — the realized, point-in-time move the market made, measured across 127 labeled events over the last three years with zero look-ahead.
AXDX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 21% | 108 |
| 30-min | -0.12% | 36% | 124 |
| 60-min | -1.16% | 34% | 125 |
| to close | -1.76% | 31% | 126 |
| Middle 50% of AXDX reactions | -3.39% to +1.56% |
|---|---|
| Median reaction (30-min) | -0.12% |
| Measured reactions | 127 |
Half of all Accelerate Diagnostics, Inc. news events land between -3.39% and +1.56% at 30 minutes.
Reaction stats as of 2026-08-31. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when AXDX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to AXDX's baseline. Nothing else.
Recent AXDX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Accelerate Diagnostics, For: May 06 | SEC filing · Form 8-K | SEC EDGAR | -1.70% | -21.36% | |
| Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets | Press release | PR Newswire | -13.40% | -48.04% | |
| Form 8-K Accelerate Diagnostics, For: May 08 | SEC filing · Form 8-K | SEC EDGAR | +2.54% | +13.85% | |
| Form 10-K/A Accelerate Diagnostics, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -2.53% | |
| Form 8-K Accelerate Diagnostics, For: Apr 22 | SEC filing · Form 8-K | SEC EDGAR | -3.37% | -9.14% | |
| Form 8-K Accelerate Diagnostics, For: Apr 10 | SEC filing · Form 8-K | SEC EDGAR | — | +3.61% | |
| Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results | Press release | PR Newswire | +0.00% | -4.50% | |
| Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance | Press release | PR Newswire | -5.88% | -10.92% | |
| Form 10-K Accelerate Diagnostics, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -4.50% | |
| Form 8-K Accelerate Diagnostics, For: Mar 21 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.50% | |
| Form 8-K Accelerate Diagnostics, For: Jan 28 | SEC filing · Form 8-K | SEC EDGAR | -0.94% | -1.87% | |
| Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results | Press release | PR Newswire | +0.00% | -3.42% | |
| Form 8-K Accelerate Diagnostics, For: Jan 10 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.42% | |
| Accelerate Diagnostics Reports Third Quarter 2024 Financial Results | Press release | PR Newswire | — | -4.69% | |
| Form 10-Q Accelerate Diagnostics, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | -4.69% | |
| Form 8-K Accelerate Diagnostics, For: Nov 07 | SEC filing · Form 8-K | SEC EDGAR | — | -4.69% | |
| Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results | Press release | PR Newswire | -0.80% | +0.00% | |
| Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System | Press release | PR Newswire | -5.03% | -4.47% | |
| Form 8-K Accelerate Diagnostics, For: Sep 30 | SEC filing · Form 8-K | SEC EDGAR | -5.03% | -4.47% | |
| Form 8-K Accelerate Diagnostics, For: Aug 26 | SEC filing · Form 8-K | SEC EDGAR | -1.36% | +3.26% | |
| Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial | Press release | PR Newswire | +0.00% | +5.07% | |
| Accelerate Diagnostics Reports Second Quarter 2024 Financial Results | Press release | PR Newswire | +0.00% | +5.07% | |
| Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results | Press release | PR Newswire | — | +2.90% | |
| Form 10-Q Accelerate Diagnostics, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +5.07% | |
| Form 8-K Accelerate Diagnostics, For: Aug 08 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +5.07% | |
| Form 8-K Accelerate Diagnostics, For: Jun 05 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.40% | |
| Form 8-K Accelerate Diagnostics, For: May 31 | SEC filing · Form 8-K | SEC EDGAR | -1.67% | -3.33% | |
| Form SD Accelerate Diagnostics, | SEC filing · Form SD | SEC EDGAR | +0.00% | -11.19% | |
| Form 8-K Accelerate Diagnostics, For: May 29 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -11.19% | |
| Form 8-K Accelerate Diagnostics, For: May 20 | SEC filing · Form 8-K | SEC EDGAR | +2.84% | +25.00% | |
| Form S-8 Accelerate Diagnostics, | SEC filing · Form S-8 | SEC EDGAR | +0.00% | -2.69% | |
| Form 10-Q Accelerate Diagnostics, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | +0.11% | |
| Form 8-K Accelerate Diagnostics, For: May 07 | SEC filing · Form 8-K | SEC EDGAR | +1.87% | +2.43% | |
| Form 8-K/A Accelerate Diagnostics, For: May 08 | SEC filing · Form 8-K | SEC EDGAR | — | +0.11% | |
| Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results | Press release | PR Newswire | +0.00% | -2.25% | |
| Form 8-K Accelerate Diagnostics, For: May 08 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.25% | |
| Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results. | Press release | PR Newswire | -1.06% | +1.28% | |
| Form 8-K Accelerate Diagnostics, For: Apr 26 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +3.01% | |
| Form DEF 14A Accelerate Diagnostics, For: May 07 | SEC filing · Form DEF | SEC EDGAR | +0.00% | +2.07% | |
| Form 10-K Accelerate Diagnostics, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -2.08% | -8.33% | |
| Form 8-K Accelerate Diagnostics, For: Mar 28 | SEC filing · Form 8-K | SEC EDGAR | -2.08% | -8.33% | |
| Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results | Press release | PR Newswire | -2.08% | -8.33% | |
| Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results. | Press release | PR Newswire | +6.44% | -1.82% | |
| Form 8-K Accelerate Diagnostics, For: Mar 04 | SEC filing · Form 8-K | SEC EDGAR | -4.78% | -4.35% | |
| Form 8-K Accelerate Diagnostics, For: Jan 19 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +6.30% | |
| Form EFFECT Accelerate Diagnostics, | SEC filing · Form EFFECT | SEC EDGAR | +2.21% | -0.79% | |
| Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement | Press release | PR Newswire | -10.48% | -0.81% | |
| Form S-1/A Accelerate Diagnostics, | SEC filing · Form S-1 | SEC EDGAR | +3.68% | -26.04% | |
| Accelerate Diagnostics Announces Launch of Proposed Public Offering | Press release | PR Newswire | +4.31% | +2.54% | |
| Form S-1/A Accelerate Diagnostics, | SEC filing · Form S-1 | SEC EDGAR | +4.31% | +2.54% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the AXDX section they belong to.
Where else AXDX is measured.
AXDX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OPGEN INC (OPGN) | 129 | 0.00% | 42% |
| Medicenna Therapeutics Corp (MDNA_TSE) | 128 | 0.00% | 45% |
| BioStem Technologies, Inc. (BSEM) | 127 | 0.00% | 48% |
| BIOTRICITY INC (BTCY) | 127 | 0.00% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Accelerate Diagnostics, Inc.'s median reaction calculated?
Every labeled AXDX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 127 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 36% of AXDX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-31.
Does AXDX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.